Tolwani AJ - Search Results

1

A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance.

Tolwani AJ, Prendergast MB, Speer RR, Stofan BS, Wille KM. Tolwani AJ, et al. Clin J Am Soc Nephrol. 2006 Jan;1(1):79-87. doi: 10.2215/CJN.00040505. Epub 2005 Nov 23. Clin J Am Soc Nephrol. 2006. PMID: 17699194

2

Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial.

Wald R, Gaudry S, da Costa BR, Adhikari NKJ, Bellomo R, Du B, Gallagher MP, Hoste EA, Lamontagne F, Joannidis M, Liu KD, McAuley DF, McGuinness SP, Nichol AD, Ostermann M, Palevsky PM, Qiu H, Pettilä V, Schneider AG, Smith OM, Vaara ST, Weir M, Dreyfuss D, Bagshaw SM; STARRT-AKI Investigators. Wald R, et al. Intensive Care Med. 2023 Nov;49(11):1305-1316. doi: 10.1007/s00134-023-07211-8. Epub 2023 Oct 10. Intensive Care Med. 2023. PMID: 37815560 Clinical Trial.

3

Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial.

Bagshaw SM, Neto AS, Smith O, Weir M, Qiu H, Du B, Wang AY, Gallagher M, Bellomo R, Wald R; STARRT-AKI Investigators. Bagshaw SM, et al. Intensive Care Med. 2022 Dec;48(12):1736-1750. doi: 10.1007/s00134-022-06912-w. Epub 2022 Nov 4. Intensive Care Med. 2022. PMID: 36331570 Clinical Trial.

4

Correction: Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial.

Bagshaw SM, Neto AS, Smith O, Weir M, Qiu H, Du B, Wang AY, Gallagher M, Bellomo R, Wald R; STARRT-AKI Investigators. Bagshaw SM, et al. Intensive Care Med. 2023 Mar;49(3):381-383. doi: 10.1007/s00134-023-06976-2. Intensive Care Med. 2023. PMID: 36757471 No abstract available.

5

Simplified citrate anticoagulation for continuous renal replacement therapy.

Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG. Tolwani AJ, et al. Kidney Int. 2001 Jul;60(1):370-4. doi: 10.1046/j.1523-1755.2001.00809.x. Kidney Int. 2001. PMID: 11422774 Free article.

6

Citrate-based replacement solutions with continuous venovenous hemofiltration: not as simple as it sounds.

Tolwani A, Wille KM. Tolwani A, et al. Am J Kidney Dis. 2006 Jun;47(6):1086; author reply 1086-7. doi: 10.1053/j.ajkd.2006.03.080. Am J Kidney Dis. 2006. PMID: 16731311 No abstract available.

7

Sustained low-efficiency dialysis.

Tolwani AJ, Wheeler TS, Wille KM. Tolwani AJ, et al. Contrib Nephrol. 2007;156:320-4. doi: 10.1159/000102122. Contrib Nephrol. 2007. PMID: 17464142 Review.

8

Standard versus high-dose CVVHDF for ICU-related acute renal failure.

Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM. Tolwani AJ, et al. J Am Soc Nephrol. 2008 Jun;19(6):1233-8. doi: 10.1681/ASN.2007111173. Epub 2008 Mar 12. J Am Soc Nephrol. 2008. PMID: 18337480 Free PMC article. Clinical Trial.

9

The epidemiology of severe acute kidney injury: from BEST to PICARD, in acute kidney injury: new concepts.

Pisoni R, Wille KM, Tolwani AJ. Pisoni R, et al. Among authors: tolwani aj. Nephron Clin Pract. 2008;109(4):c188-91. doi: 10.1159/000142927. Epub 2008 Sep 18. Nephron Clin Pract. 2008. PMID: 18802366 Review.

10

Anticoagulation for continuous renal replacement therapy.

Tolwani AJ, Wille KM. Tolwani AJ, et al. Semin Dial. 2009 Mar-Apr;22(2):141-5. doi: 10.1111/j.1525-139X.2008.00545.x. Semin Dial. 2009. PMID: 19426417 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page